Company: MIRM
Filing Date: 2025-04-14
Form Type: DEF 14A
Source: 0001759425-25-000022
Chunk: 71

Company: Mirum Pharmaceuticals, Inc.
Filing Date: 2025-04-14
Form: DEF 14A
Chunk 71
---
 the Eventide website. The information on the Eventide website is not incorporated by reference into this Proxy Statement or our Annual Report.

(6) This information is based on a Schedule 13G filed with the SEC on February 13, 2024 by The Vanguard Group, Inc. ( “Vanguard” ). According to the Schedule 13G, as of December 29, 2023, Vanguard has shared power to vote or direct the vote of 46,538 shares of common stock, sole power to dispose or direct the disposition of 2,397,149 shares of common stock, and shared power to dispose or direct the disposition of 79,095 shares of common stock. The Schedule 13G provides information only as of December 29, 2023 and, consequently, the beneficial ownership of the above-mentioned entity may have changed between December 29, 2023 and February 15, 2025. The address for Vanguard is 100 Vanguard Boulevard, Malvern, Pennsylvania 19355.

#### Mirum Pharmaceuticals2025 Proxy Statement57

### TABLE OF CONTENTS
Security Ownership of Certain Beneficial Owners and Management

(7) For Mr. Bjerkholt, consists of the following held directly: (i) 35,946 shares of common stock, (ii) 52,874 shares of common stock subject to options that are exercisable within 60 days of the Measurement Date, (iii) 2,667 shares underlying restricted stock units that will vest and settle within 60 days of the Measurement Period and (iv) 10,000 shares underlying performance-based restricted stock units that will vest and settle within 60 days of the Measurement Period.

(8) For Ms. Brege, consists of the following held directly: (i) 10,000 shares of common stock and (ii) 82,167 shares of common stock subject to options that are exercisable within 60 days of the Measurement Date.

(9) For Dr. Cardon, consists of the following held directly: 29,750 shares of common stock subject to options that are exercisable within 60 days of the Measurement Date.

(10) For Mr. Fairey, consists of the following held directly: 63,750 shares of common stock subject to options that are exercisable within 60 days of the Measurement Date.

(11) For Dr. Fischer, consists of the following held directly: (i) 6,750 shares of common stock and (ii)